Key Market Indicators
Dane Antidepressant Medicine Sales are projected to plummet to approximately $3 million by 2028, a sharp decline from $20 million in 2023. This marks a significant year-on-year compound annual growth rate (CAGR) decrease of 29%. Since 2002, the Danish market has experienced a consistent drop, averaging a 10.6% decrease annually. In 2023, Denmark ranked 13th globally in antidepressant medicine sales, with Slovakia narrowly surpassing it at $20 million. Leading the global rankings for antidepressant sales in 2023 were Spain, Italy, and Australia, occupying the second, third, and fourth spots respectively.
